Atlas Trials

Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2

Clinical trial NCT03296826 · RECRUITING

Trial details

NCT number
NCT03296826
Sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Status
RECRUITING
Study type
OBSERVATIONAL
BRCA1 and/or BRCA2 Variant CarriersOvarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma
Start date
2017-11-08
Primary completion
2032-03-31
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.